TW202604499A - 填充於樹脂製容器之含銀鹽眼科用水性組合物 - Google Patents
填充於樹脂製容器之含銀鹽眼科用水性組合物Info
- Publication number
- TW202604499A TW202604499A TW114132350A TW114132350A TW202604499A TW 202604499 A TW202604499 A TW 202604499A TW 114132350 A TW114132350 A TW 114132350A TW 114132350 A TW114132350 A TW 114132350A TW 202604499 A TW202604499 A TW 202604499A
- Authority
- TW
- Taiwan
- Prior art keywords
- ophthalmic
- sodium
- silver
- eye drops
- aqueous composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Bridges Or Land Bridges (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020062252 | 2020-03-31 | ||
| JP2020-062252 | 2020-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202604499A true TW202604499A (zh) | 2026-02-01 |
Family
ID=77930318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW114132350A TW202604499A (zh) | 2020-03-31 | 2021-02-26 | 填充於樹脂製容器之含銀鹽眼科用水性組合物 |
| TW110107071A TWI896607B (zh) | 2020-03-31 | 2021-02-26 | 填充於樹脂製容器之含銀鹽眼科用水性組合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110107071A TWI896607B (zh) | 2020-03-31 | 2021-02-26 | 填充於樹脂製容器之含銀鹽眼科用水性組合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230145529A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4129341A4 (cg-RX-API-DMAC10.html) |
| JP (4) | JP7053966B2 (cg-RX-API-DMAC10.html) |
| KR (2) | KR20240135080A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115348871B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3176584A1 (cg-RX-API-DMAC10.html) |
| TW (2) | TW202604499A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021199814A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022044701A (ja) * | 2022-01-24 | 2022-03-17 | 参天製薬株式会社 | インジェクションブロー成形されたマルチドーズ型点眼容器に収容される水性懸濁液 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| JP4683835B2 (ja) * | 2003-12-01 | 2011-05-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| KR100557679B1 (ko) * | 2004-01-07 | 2006-03-07 | 뉴바이오 (주) | 4차암모늄의 공중합에 의한 콘택트렌즈제조방법 |
| JP4856392B2 (ja) | 2004-04-23 | 2012-01-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| JP2006162648A (ja) | 2004-12-02 | 2006-06-22 | Konica Minolta Business Technologies Inc | 現像装置及び画像形成装置 |
| MX2010004211A (es) * | 2007-10-16 | 2010-06-30 | Sun Pharma Advanced Res Co Ltd | Composicion oftalmica que comprende una prostaglandina. |
| TW201340960A (zh) * | 2012-02-27 | 2013-10-16 | Rohto Pharma | 眼科用組成物套組 |
| US20150366879A1 (en) * | 2013-02-15 | 2015-12-24 | Senju Pharmaceutical Co., Ltd. | Difluprednate emulsion composition containing antimicrobial metal |
| TWI623313B (zh) * | 2013-03-13 | 2018-05-11 | Santen Pharmaceutical Co Ltd | 瞼板腺功能障礙之治療劑 |
| EA034517B1 (ru) * | 2014-12-25 | 2020-02-17 | Сантен Фармасьютикал Ко., Лтд. | Водный офтальмологический раствор |
| JP6611444B2 (ja) * | 2015-03-24 | 2019-11-27 | ロート製薬株式会社 | 眼科用組成物 |
| TWI743858B (zh) | 2015-06-05 | 2021-10-21 | 日商參天製藥股份有限公司 | 使水性點眼液中之洛赫西定類安定化之方法 |
| JP6615548B2 (ja) * | 2015-08-06 | 2019-12-04 | ロート製薬株式会社 | 眼科組成物 |
| WO2019107569A1 (ja) * | 2017-12-01 | 2019-06-06 | 参天製薬株式会社 | 眼科用製品 |
| CN116018882A (zh) * | 2018-06-28 | 2023-04-25 | Csp高级解决方案株式会社 | 流行性角膜结膜炎的治疗用滴眼剂、生成该滴眼剂的等离子体活性滴眼剂生成装置及流行性角膜结膜炎的治疗方法 |
| JP7139206B2 (ja) | 2018-09-21 | 2022-09-20 | 小林製薬株式会社 | 医薬組成物 |
-
2021
- 2021-02-26 EP EP21781950.7A patent/EP4129341A4/en active Pending
- 2021-02-26 CN CN202180026304.3A patent/CN115348871B/zh active Active
- 2021-02-26 JP JP2021552932A patent/JP7053966B2/ja active Active
- 2021-02-26 US US17/914,976 patent/US20230145529A1/en not_active Abandoned
- 2021-02-26 TW TW114132350A patent/TW202604499A/zh unknown
- 2021-02-26 KR KR1020247029902A patent/KR20240135080A/ko active Pending
- 2021-02-26 CA CA3176584A patent/CA3176584A1/en active Pending
- 2021-02-26 KR KR1020227037013A patent/KR102705675B1/ko active Active
- 2021-02-26 WO PCT/JP2021/007366 patent/WO2021199814A1/ja not_active Ceased
- 2021-02-26 TW TW110107071A patent/TWI896607B/zh active
-
2022
- 2022-03-31 JP JP2022058115A patent/JP7169477B2/ja active Active
- 2022-10-26 JP JP2022171413A patent/JP7721498B2/ja active Active
-
2025
- 2025-07-29 JP JP2025126160A patent/JP2025146955A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3176584A1 (en) | 2021-10-07 |
| JP2023001184A (ja) | 2023-01-04 |
| TWI896607B (zh) | 2025-09-11 |
| JP2025146955A (ja) | 2025-10-03 |
| KR20240135080A (ko) | 2024-09-10 |
| CN115348871A (zh) | 2022-11-15 |
| JPWO2021199814A1 (cg-RX-API-DMAC10.html) | 2021-10-07 |
| JP7721498B2 (ja) | 2025-08-12 |
| US20230145529A1 (en) | 2023-05-11 |
| TW202203920A (zh) | 2022-02-01 |
| EP4129341A1 (en) | 2023-02-08 |
| CN115348871B (zh) | 2025-08-08 |
| EP4129341A4 (en) | 2024-04-24 |
| KR20220161379A (ko) | 2022-12-06 |
| JP2022087168A (ja) | 2022-06-09 |
| KR102705675B1 (ko) | 2024-09-11 |
| WO2021199814A1 (ja) | 2021-10-07 |
| JP7053966B2 (ja) | 2022-04-12 |
| JP7169477B2 (ja) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5726774B2 (ja) | ロテプレドノールエタボネートおよびトブラマイシンの局所眼科用懸濁液 | |
| TWI832920B (zh) | 抑制軟性隱形眼鏡變質之眼科用組成物 | |
| JP6903448B2 (ja) | ドルゾラミドとブリモニジンを含む医薬組成物 | |
| JP2024116303A (ja) | 点眼剤 | |
| JP2025146955A (ja) | 樹脂製容器に充填された銀塩含有眼科用水性組成物 | |
| JP7317714B2 (ja) | 眼科用製品 | |
| JPWO2012099142A1 (ja) | 保存効力を有するブロムフェナク水性液剤組成物 | |
| JP2014512387A (ja) | 二つの異なる粘性増強剤を有する粘性増強システムを備えた眼科用組成物 | |
| JP6267394B1 (ja) | 水溶性粘稠化剤を含有する医薬組成物 | |
| JP7144630B2 (ja) | レバミピドまたはその塩および高分子を含有する水性懸濁液 | |
| JP2019006756A (ja) | 水溶性粘稠化剤を含有する医薬組成物 | |
| JP6702754B2 (ja) | ドルゾラミドを含有する防腐剤 | |
| JP6877613B2 (ja) | 防腐効果のある医薬の組合せ | |
| TW202404569A (zh) | 含有賽佩普斯特(Sepetaprost)之眼科用組合物 |